Over 100,000 Americans are diagnosed each year with colon cancer and approximately 90% are treated surgically. Most undergo a curative intent resection, but 30 to 50 percent will have a recurrence of their disease. While much of the variability in outcomes depends on the stage of the disease and other tumor variables, it is now clear that surgeon variables such as caseload and training affect both local recurrence and patient survival. Operative techniques including laparoscopic and other minimally invasive procedures and surgical decisions including choice of operative procedure, management of cancer arising in polyps and treatment of metastatic disease affect outcomes. The role of postoperative surveillance for recurrence remains controversial.
机构:
Mayo Med Ctr, Dept Med, Div Gastroenterol & Hepatol, Rochester, MN 55905 USAMayo Med Ctr, Dept Med, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA
Adler, DG
Baron, TH
论文数: 0引用数: 0
h-index: 0
机构:
Mayo Med Ctr, Dept Med, Div Gastroenterol & Hepatol, Rochester, MN 55905 USAMayo Med Ctr, Dept Med, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA
机构:
Mayo Clin & Mayo Fdn, Dept Med, Div Gastroenterol & Hepatol, Rochester, MN 55905 USAMayo Clin & Mayo Fdn, Dept Med, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA
机构:
Mayo Med Ctr, Dept Med, Div Gastroenterol & Hepatol, Rochester, MN 55905 USAMayo Med Ctr, Dept Med, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA
Adler, DG
Baron, TH
论文数: 0引用数: 0
h-index: 0
机构:
Mayo Med Ctr, Dept Med, Div Gastroenterol & Hepatol, Rochester, MN 55905 USAMayo Med Ctr, Dept Med, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA
机构:
Mayo Clin & Mayo Fdn, Dept Med, Div Gastroenterol & Hepatol, Rochester, MN 55905 USAMayo Clin & Mayo Fdn, Dept Med, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA